The GRAIT Awards Program is an annual European and Middle East award to encourage clinicians and researchers to increase insight into immune thrombocytopenia (ITP) or to improve knowledge of the Spleen Tyrosine Kinase (SYK) inhibition as mechanism of action.

It provides financial support to the awarded scientists and clinicians who wish to undertake a research project that seeks to improve ITP awareness, diagnosis, clinical course, management or projects aimed to improve knowledge of the Spleen Tyrosine Kinase (SYK) inhibition as mechanism of action.

We hope this program will enhance innovation in the pathology or management of the disease in general or in the mechanism of SYK inhibition, ultimately to benefit patient care.

Application process for the GRAIT Awards 2024 closed.
The awardees will be announced in December 2024.

Applications for the next edition 2025 will be accepted between between January 30 and June 28, 2025.

To see the 2023 GRAIT Awards winner, please click here.